The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
about
Towards tumor immunodiagnosticsTumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast CancerTumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune TargetingCurrent Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast CancerHyaluronan, Inflammation, and Breast Cancer ProgressionPossible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responsesMyeloid cells in circulation and tumor microenvironment of breast cancer patientsThe Role of Neoadjuvant Trials in Drug Development for Solid Tumors.The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiationFERAL: network-based classifier with application to breast cancer outcome prediction.Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant SettingTumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials.Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis.Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapyTumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer.High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis.Correction: The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.The Predictive and Prognostic Role of Stromal Tumor-infiltrating Lymphocytes in HER2-positive Breast Cancer with Trastuzumab-based Treatment: a Meta-analysis and Systematic Review.Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer.Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer.Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer.Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.The Major Role of NF-kB in the Depth of Invasion on Acral Melanoma by Decreasing CD8+ T Cells.Prognostic Significance of Stromal Versus Intratumoral Infiltrating Lymphocytes in Different Subtypes of Breast Cancer Treated With Cytotoxic Neoadjuvant Chemotherapy.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in IHow many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancerPredictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
P2860
Q26738691-875F890C-B6B5-4099-ADFF-EF31DCB1341CQ26745446-10730203-EF74-4D4A-958B-08574369DEF0Q26747792-40901FC6-B63B-4BE9-9D5D-BF8D8FFF3756Q26798074-F0D7EFB5-90CA-4621-91CD-1BBACD8ABB18Q27006607-45E32E3C-4237-4ED1-A031-338D92A6BC4AQ28068802-F9E2F434-0428-4C82-B253-FD62158E903EQ33729434-4F17BFE9-B2AA-4CE0-AA2F-CB065A5B8C7FQ33886353-8F4624F5-E9CF-474A-AE3A-FA256A4E026CQ36069982-66E73C59-8321-4E26-9995-F40A7CC9CE77Q36614060-BB99044E-3979-4C72-844B-E98C3DE9380CQ36673469-27ED6DDD-F771-4F78-9B6E-5A0294B20625Q36782680-B6596A08-59BB-4EB1-8D74-6137ECD280E3Q37042605-4111EDD5-1EAB-4848-BFD9-8D4E1129BBADQ37536862-7FB983C1-E4F5-4514-A803-4C7297668B2CQ37626786-6C324B85-B909-46FE-9DEF-4B65F008D3BEQ38686046-62C1A2D8-880A-451D-BE85-C46CC349166DQ38734804-4FA20A27-08CF-4270-809C-4641C45F27DBQ39685538-A42249CA-7C52-42F1-AEAB-115BCA513FBFQ40404266-D1BDF93F-270A-4CA0-9829-DB8D7AA81C2DQ41810793-9A82CB18-F9AB-45C1-B137-B8DE427CEFD6Q42730619-297BE5E4-CA45-414C-91B4-9B248A03F434Q43172959-0DF05518-DBA2-4098-9EA2-61CD4AF6BE07Q47109695-E880E146-BABB-4A1C-B1E5-52E791A4E5AFQ47734351-72A91FE1-1506-418D-AC9C-A1D4FC393CE9Q47863345-203A21F6-A86C-4FA3-BC2F-749930E810C1Q48219547-AEE2F8E2-5A7B-478A-A3D7-99B9A68B522BQ48341168-1E21EF32-6193-45B8-9310-B4733140E2D7Q49564212-0C5E28BF-15CE-4C46-89AF-34D08C3C2FD9Q49679692-4F87A973-8D10-4EE7-B9C0-8F36491EA2CFQ49721138-4177064C-01C8-4B0D-A664-3A62884AFA16Q52881463-F80A18C9-2CCD-42B7-9824-A8E7DF302726Q53406743-F37C8E19-40A8-419E-ABB4-CDA3C341FD79Q54481477-BE2AD59B-043B-42BE-B05C-DDA170F50AF8Q54685474-2E5A28EA-E0D4-4FE3-BC38-462775C58F60Q55316580-C0E92894-8A20-476A-9D7C-648794D07D80Q58098917-D3EECDF4-7899-4362-A713-EF27CC99D58DQ58781862-BD58C707-7DEB-4106-9704-3E6462A3D2BC
P2860
The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The value of tumor infiltratin ...... atic review and meta-analysis.
@ast
The value of tumor infiltratin ...... atic review and meta-analysis.
@en
The value of tumor infiltrating lymphocytes
@nl
type
label
The value of tumor infiltratin ...... atic review and meta-analysis.
@ast
The value of tumor infiltratin ...... atic review and meta-analysis.
@en
The value of tumor infiltrating lymphocytes
@nl
prefLabel
The value of tumor infiltratin ...... atic review and meta-analysis.
@ast
The value of tumor infiltratin ...... atic review and meta-analysis.
@en
The value of tumor infiltrating lymphocytes
@nl
P2093
P2860
P31
P921
P1433
P1476
The value of tumor infiltratin ...... atic review and meta-analysis.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0115103
P407
P5008
P577
2014-12-12T00:00:00Z